HB 1741 Providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off label use to treat coronavirus infections causing respiratory syndrome related illnesses
Pennsylvania 2021-2022 Regular Session
Providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory syndrome-related illnesses.
HB-1741
About HB-1741
An Act providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory syndrome-related illnesses.
HB-1741: Providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory syndrome-related illnesses.
You have voted HB-1741: Providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory syndrome-related illnesses..